Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6PLK

Crystal structure of ZIKV-116 Fab in complex with ZIKV envelope DIII

6PLK の概要
エントリーDOI10.2210/pdb6plk/pdb
分子名称ZIKV-116 heavy chain, ZIKV-116 light chain, Env, ... (4 entities in total)
機能のキーワードhuman antibody, zikv-diii, antiviral protein, structural genomics, center for structural genomics of infectious diseases, csgid
由来する生物種Homo sapiens
詳細
タンパク質・核酸の鎖数6
化学式量合計118949.84
構造登録者
Zhao, H.,Fremont, D.H.,Center for Structural Genomics of Infectious Diseases (CSGID) (登録日: 2019-07-01, 公開日: 2019-11-20, 最終更新日: 2024-11-13)
主引用文献Zhao, H.,Xu, L.,Bombardi, R.,Nargi, R.,Deng, Z.,Errico, J.M.,Nelson, C.A.,Dowd, K.A.,Pierson, T.C.,Crowe, J.E.,Diamond, M.S.,Fremont, D.H.
Mechanism of differential Zika and dengue virus neutralization by a public antibody lineage targeting the DIII lateral ridge.
J.Exp.Med., 217:-, 2020
Cited by
PubMed Abstract: We previously generated a panel of human monoclonal antibodies (mAbs) against Zika virus (ZIKV) and identified one, ZIKV-116, that shares germline usage with mAbs identified in multiple donors. Here we show that ZIKV-116 interferes with ZIKV infection at a post-cellular attachment step by blocking viral fusion with host membranes. ZIKV-116 recognizes the lateral ridge of envelope protein domain III, with one critical residue varying between the Asian and African strains responsible for differential binding affinity and neutralization potency (E393D). ZIKV-116 also binds to and cross-neutralizes some dengue virus serotype 1 (DENV1) strains, with genotype-dependent inhibition explained by variation in a domain II residue (R204K) that potentially modulates exposure of the distally located, partially cryptic epitope. The V-J reverted germline configuration of ZIKV-116 preferentially binds to and neutralizes an Asian ZIKV strain, suggesting that this epitope may optimally induce related B cell clonotypes. Overall, these studies provide a structural and molecular mechanism for a cross-reactive mAb that uniquely neutralizes ZIKV and DENV1.
PubMed: 31757867
DOI: 10.1084/jem.20191792
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 6plk
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon